13F Filings History of DCVC Bio GP, LLC
- Form 13F summary
-
- DCVC Bio GP, LLC Form 13F history summarizes parsed U.S.-listed equity disclosures for this manager.
- Form 13F is generally due within 45 days after each calendar quarter ends.
- DCVC Bio GP, LLC reported 1 equity holding with a total reported market value of $313,000 for Q2 2022.
- Manager signature
- Zachary Bogue - Managing Member of a Managing Member
- Manager location
- Palo Alto, CA
13F snapshot
Latest parsed holdings, value, and filing-period context.
1 signal
Manager
Names, identifiers, and filing context for this profile.
2 identity fields
Follow Filing Activity
Follow DCVC Bio GP, LLC with Pro and return when a new 13F portfolio filing changes the record on this page.
Pro alert delivery is coming soon and remains tied to source-backed filing changes rather than inferred market advice.
Holdings Value
Form 13F evidence
Quarterly portfolio filings
SEC-reported 13F quarters for this filer, ordered by the latest accepted filing.
Latest quarter
Q2 2022
Latest value
$313,000
Quarter delta
$0
Accepted
14 Nov 2022, 09:28
Rows shown
1-4 of 4
| Quarter | Holdings | SEC-reported value | Bought | Sold | Net | Top Holdings | Form Type | Accepted by SEC |
|---|---|---|---|---|---|---|---|---|
| Q3 2022 | 0 | $0 | $0 | -$313,000 | -$313,000 | 13F-HR | 14 Nov 2022, 09:28 | |
| Q2 2022 | 1 | $313,000 | $0 | -$77,436,930 | -$77,436,930 | ABCL | 13F-HR | 14 Nov 2022, 09:28 |
| Q1 2022 | 1 | $71,231,000 | $0 | $0 | $0 | ABCL | 13F-HR | 14 Nov 2022, 09:28 |
| Q4 2021 | 1 | $104,472,000 | $0 | $0 | $0 | ABCL | 13F-HR | 14 Feb 2022, 15:18 |